Skip to main content
SpringerLink
Log in

Anorexia

  • Chapter
Book cover Cachexia and Wasting: A Modern Approach

  • 2155 Accesses

Abstract

In medicine, specific combinations of symptoms and signs contribute to establishing a diagnosis. However, symptoms or constellations of symptoms (i.e., syndromes) per se may not be specific for a single disease; rather, they are observed during the clinical course of a number of acute and chronic diseases. Among them, anorexia is a highly prevalent syndrome that heavily impacts on the prognosis of patients suffering from acute (i.e. sepsis) and chronic (i.e. cancer, liver cirrhosis, chronic renal failure, chronic obstructive pulmonary [COPD]) diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Murray MJ, Murray AB (1979) Anorexia of infection as a mechanism of host defense. Am J Clin Nutr 32:593–596

    PubMed  CAS  Google Scholar 

  2. Stubbs RJ, Hughes DA, Johnstone AM et al (2000) The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new handheld computerized systems for temporal tracking of appetite ratings. Br J Nutr 84:405–415

    PubMed  CAS  Google Scholar 

  3. Rossi Fanelli F, Cangiano C, Ceci F et al (1986) Plasma tryptophan and anorexia in human cancer. Eur J Cancer Clin Oncol 22:89–95

    Article  PubMed  CAS  Google Scholar 

  4. Geels P, Eisenhauer E, Bezjak A et al (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18:2395–2405

    PubMed  CAS  Google Scholar 

  5. DeWys WD, Begg C, Lavin PT et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am JMed 69:491–497

    CAS  Google Scholar 

  6. Sutton LM, Demark-Wahnefried W, Clipp EC (2003) Management of terminal cancer in elderly patients. Lancet Oncol 4:149–157

    Article  PubMed  Google Scholar 

  7. Pirovano M, Maltoni M, Nanni O et al (1999) A new palliative score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17:231–239

    Article  PubMed  CAS  Google Scholar 

  8. Maltoni M, Nanni O, Pirovano M et al (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 17:240–247

    Article  PubMed  CAS  Google Scholar 

  9. Daly JM, Redmond HP, Gallagher H (1992) Perioperative nutrition in cancer patients. JPEN 16(Suppl 6):100S–105S

    CAS  Google Scholar 

  10. Marchesini G, Bianchi G, Merli M et al for the Italian BCAA Study Group (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801

    Article  PubMed  CAS  Google Scholar 

  11. Hiroshige K, Sonta T, Suda T et al (2001) Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant 16:1856–1862

    Article  PubMed  CAS  Google Scholar 

  12. Edmonds P, Karlsen S, Khan S, Addington-Hall J (2001) A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 15:287–295

    Article  PubMed  CAS  Google Scholar 

  13. Nordgren L, Sorensen S (2003) Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2:213–217

    Article  PubMed  Google Scholar 

  14. Lynn J, Teno JM, Phillips RS et al (1997) Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Int Med 126:97–106

    PubMed  CAS  Google Scholar 

  15. Gibbs JS, McCoy AS, Gibbs LM et al (2002) Living with and dying from heart failure: the role of palliative care. Heart 88(Suppl 2):ii36–ii39

    PubMed  Google Scholar 

  16. Rossi Fanelli F, Muscaritoli M, Cangiano C et al (1999) The basis for a rational nutritional approach to patients with cancer. In: Abraham NG, Tabilio A, Martelli M et al (eds) Molecular biology of hematopoiesis. Kluwer Academic/Plenum Publishers, New York, pp 229–234

    Google Scholar 

  17. Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2:862–871

    Article  PubMed  CAS  Google Scholar 

  18. Maltoni M, Pirovano M, Scarpi E et al (1995) Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 75:2613–2622

    Article  PubMed  CAS  Google Scholar 

  19. Apolone G, De Carli G, Brunetti M, Garattini S (2001) Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval. Pharmacoeconomics 19:1727–1729

    Article  Google Scholar 

  20. Schwartz MW, Woods SC, Porte DJr et al (2000) Central nervous system control of food intake. Nature 404:661–671

    PubMed  CAS  Google Scholar 

  21. Janik JE, Curti BD, Considine RV et al (1997) Interleukin-1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 82:3084–3086

    Article  PubMed  CAS  Google Scholar 

  22. Chance WT, Sheriff S, Moore J et al (1998) Reciprocal changes in hypothalamic receptor binding and circulating leptin in anorectic tumor-bearing rats. Brain Res 803:27–33

    Article  PubMed  CAS  Google Scholar 

  23. Simons JP, Schols AM, Campfield LA et al (1997) Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci 93:273–277

    PubMed  CAS  Google Scholar 

  24. Bing C, Taylor S, Tisdale MJ, Williams G (2001) Cachexia in MAC 16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. J Neurochem 79:1004–1012

    Article  PubMed  CAS  Google Scholar 

  25. Mantovani G, Macciò A, Mura L et al (2000) Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med 78:554–561

    Article  PubMed  CAS  Google Scholar 

  26. Stenvinkel P, Lindholm B, Lonnqvist F et al (2000) Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 11:1303–1309

    PubMed  CAS  Google Scholar 

  27. Ben-Ari Z, Schafer Z, Sulkes J et al (2002) Alterations in serum leptin in chronic liver disease. Dig Dis Sci 47:183–189

    Article  PubMed  CAS  Google Scholar 

  28. Kahler A, Zimmermann M, Langhans W (1999) Suppression of hepatic fatty acid oxidation and food intake in men. Nutrition 15:819–828

    Article  PubMed  CAS  Google Scholar 

  29. Loftus TM, Jaworsky DE, Frehywot GL et al (2000) Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288:2379–2381

    Article  PubMed  CAS  Google Scholar 

  30. Rasmussen BB, Holmback UC, Volpi E et al (2002) Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 110:1687–1693

    Article  PubMed  CAS  Google Scholar 

  31. Peluso G, Nicolai R, Reda E et al (2000) Cancer and anticancer therapy-induced modification on metabolism mediated by carnitine system. J Cell Physiol 182:339–350

    Article  PubMed  CAS  Google Scholar 

  32. Laviano A, Meguid MM, Renvyle T et al (1996) Carnitine supplementation accelerates normalization of food intake depressed during TPN. Physiol Behav 60:317–320

    Article  PubMed  CAS  Google Scholar 

  33. Li JL, Zheng FL, Tan HB et al (2003) Orexin A and neuropeptide Y in plasma and hypothalamus of rats with chronic renal failure. Zhonghua Yi Xue Za Zhi 83:992–995

    PubMed  CAS  Google Scholar 

  34. Rossi Fanelli F, Cangiano C (1991) Increased availability of tryptophan in brain as common pathogenic mechanism for anorexia associated with different diseases. Nutrition 7:364–367

    PubMed  CAS  Google Scholar 

  35. Laviano A, Meguid MM, Yang Z-J et al (1996) Cracking the riddle of cancer anorexia. Nutrition 12:706–710

    PubMed  CAS  Google Scholar 

  36. Chance WT, Balasubramaniam A, Fischer JE (1995) Neuropeptide Y and the development of cancer anorexia. Ann Surg 221:579–587

    Article  PubMed  CAS  Google Scholar 

  37. Chance WT, Sheriff S, Kasckow JW et al (1998) NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats. Regul Pept 75–76:347–353

    Article  PubMed  Google Scholar 

  38. Plata-Salaman CR, Ilyin SE, Gayle D (1998) Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol 275:R566–R573

    PubMed  CAS  Google Scholar 

  39. Jatoi A, Loprinzi CL, Sloan JA et al (2001) Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Treatment Group exploratory investigation. Cancer 92:629–633

    Article  PubMed  CAS  Google Scholar 

  40. Meguid MM, Ramos EJ, Laviano A et al (2004) Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides 25:261–266

    Article  PubMed  CAS  Google Scholar 

  41. Makarenko IG, Meguid MM, Gatto L et al (2003) Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Res 961:100–108

    Article  PubMed  CAS  Google Scholar 

  42. Aguilera A, Codoceo R, Selgas R et al (1998) Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant 13:1476–1483

    Article  PubMed  CAS  Google Scholar 

  43. Marks DL, Ling N, Cone RD (2001) Role of central melanocortin system in cachexia. Cancer Res 61:1432–1438

    PubMed  CAS  Google Scholar 

  44. Wisse BE, Frayo RS, Schwartz MW, Cummings DE (2001) Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 142:3292–3301

    Article  PubMed  CAS  Google Scholar 

  45. Plata-Salaman CR (1996) Anorexia during acute and chronic disease. Nutrition 12:69–78

    Article  PubMed  CAS  Google Scholar 

  46. Aguilera A, Selgas R, Codoceo R, Bajo A (2000) Uremic anorexia: a consequence of persistently high brain serotonin levels? The tryptophan/serotonin disorder hypothesis. Perit Dial Int 20:810–816

    PubMed  CAS  Google Scholar 

  47. Opara El, Laviano A, Meguid MM, Yang Z-J (1995) Correlation between food intake and CSF IL-la in anorectic tumor bearing rats. Neuroreport 6:750–752

    Article  PubMed  CAS  Google Scholar 

  48. Laviano A, Gleason JR, Meguid MM et al (2000) Effects of intra-VMN mianserin and IL-Ira on meal number in anorectic tumor-bearing rats. J Investig Med 48:40–48

    PubMed  CAS  Google Scholar 

  49. Pereira BJ, Shapiro L, King AJ et al (1994) Plasma levels of IL-1 beta, TNF-alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890–896

    Article  PubMed  CAS  Google Scholar 

  50. Cangiano C, Testa U, Muscaritoli M et al (1994) Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation. Anticancer Res 14:1451–1456

    PubMed  CAS  Google Scholar 

  51. Wang W, Lonnroth C, Svanberg E, Lundholm K (2001) Cytokine and cyclooxigenase-2 protein in brain areas of tumor-bearing mice with prostanoidrelated anorexia. Cancer Res 61:4707–4715

    PubMed  CAS  Google Scholar 

  52. Wang W, Danielsson A, Svanberg E, Lundholm K (2003) Lack of effects by tricyclic antidepressant and serotonin inhibitors on anorexia in MCG 101 tumor bearing mice with eicosanoid-related anorexia. Nutrition 19:47–53

    Article  PubMed  Google Scholar 

  53. Inui A (1999) Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 59:4493–4501

    PubMed  CAS  Google Scholar 

  54. Heisler LK, Cowley MA, Tecott LH et al (2002) Activation of central melanocortin pathways by fenfluramine. Science 297:609–611

    Article  PubMed  CAS  Google Scholar 

  55. Shintani F, Kanba S, Nakaki T et al (1993) Interleukin-lbeta augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J Neurosci 13:3574–3581

    PubMed  CAS  Google Scholar 

  56. Blaha V, Yang ZJ, Meguid MM et al (1998) Ventromedial nucleus of hypothalamus is related to the development of cancer-induced anorexia: in vivo microdialysis study. Acta Medica (Hradec Kralove) 41:3–11

    CAS  Google Scholar 

  57. Diksic M, Young SN (2001) Study of the brain serotonergic system with labelled a-methyl-L-tryptophan. J Neurochem 78:1185–1200

    Article  PubMed  CAS  Google Scholar 

  58. Cangiano C, Cascino A, Ceci F et al (1990) Plasma and CSF tryptophan in cancer anorexia. J Neural Transm (Gen Sect) 81:225–233

    Article  CAS  Google Scholar 

  59. Laviano A, Cangiano C, Preziosa I et al (1997) Plasma tryptophan and anorexia in liver cirrhosis. Int J Eating Disord 21:181–186

    Article  CAS  Google Scholar 

  60. Chance WT, von Meyenfeldt M, Fischer JE (1983) Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia. Pharmacol Biochem Behav 18:115–121

    Article  PubMed  CAS  Google Scholar 

  61. Laviano A, Rossi Fanelli F (2003) Pathogenesis of cancer anorexia. Still doubts after all these years? Nutrition 19:67–68

    Article  PubMed  Google Scholar 

  62. Torelli GF, Meguid MM, Moldawer LL et al (1999) Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats. Am J Physiol 277:R850–R855

    PubMed  CAS  Google Scholar 

  63. Inui A (2002) Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52:72–91

    Article  PubMed  Google Scholar 

  64. Mantovani G, Macciò A, Bianchi A et al (1995) Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Int J Clin Lab Res 25:135–141

    Article  PubMed  CAS  Google Scholar 

  65. Mantovani G, Macciö A, Esu S et al (1997) Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur J Cancer 33:602–607

    Article  PubMed  CAS  Google Scholar 

  66. Jatoi A, Windschitl HE, Loprinzi CL et al (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer treatment Group study. J Clin Oncol 20:567–573

    Article  PubMed  CAS  Google Scholar 

  67. Loprinzi CL, Kugler JW, Sloan JA et al (1999) Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17:3299–3306

    PubMed  CAS  Google Scholar 

  68. Calder PC (2002) Dietary modifications of inflammation with lipids. Proc Nutr Soc 61:345–358

    Article  PubMed  CAS  Google Scholar 

  69. Bruera E, Strasser F, Palmer JL et al (2003) Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21:129–134

    Article  PubMed  CAS  Google Scholar 

  70. Cahlin C, Gelin J, Delbro D et al (2000) Effect of cyclooxigenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cachexia related to prostanoids. Cancer Res 60:1742–1749

    PubMed  CAS  Google Scholar 

  71. Lundholm K, Gelin J, Hyltander A et al (1994) Antiinflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 54:5602–5606

    PubMed  CAS  Google Scholar 

  72. Squadrito F, Calapai G, Altavilla D et al (1994) Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase. Eur J Pharmacol 255:51–55

    Article  PubMed  CAS  Google Scholar 

  73. Lugarini F, Hrupka BJ, Schwartz GJ et al (2002) A role for cyclooxygenase-2 in lipopolysaccharideinduced anorexia in rats. Am J Physiol Regul Integr Comp Physiol 283:R862–R868

    PubMed  CAS  Google Scholar 

  74. Nakamura K, Li YQ, Kaneko T et al (2001) Prostaglandin E3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain. Neuroscience 103:763–775

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, University of Rome La Sapienza, Rome, Italy

    Alessandro Laviano & Filippo Rossi Fanelli

  2. Department of Surgery, Surgical Metabolism and Nutrition Laboratory, Neuroscience Programs,University Hospital, Upstate Medical University, Syracuse, NY, USA

    Michael M. Meguid

Authors
  1. Alessandro Laviano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael M. Meguid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Filippo Rossi Fanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, University of Cagliari, Cagliari, Italy

    Giovanni Mantovani

  2. Department of Clinical Cardiology, Imperial College, NHLI, London, UK

    Stefan D. Anker

  3. Department of Cardiology Charité, Applied Cachexia Research, Campus Virchow-Klinikum, Berlin, Germany

    Stefan D. Anker

  4. Department of Behavioral Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    Akio Inui

  5. GRECC, VA Medical Center and Division of Geriatric Medicine, Saint Louis University, St. Louis, MO, USA

    John E. Morley

  6. Department of Clinical Medicine, University of Rome, La Sapienza, Rome, Italy

    Filippo Rossi Fanelli

  7. Department of Infectious Diseases, IRCCS S.Matteo Polyclinic, University of Pavia, Pavia, Italy

    Daniele Scevola

  8. Bone Marrow and Blood Stem Cell Transplantation Program, Center for Lymphoma and Myeloma, New York Presbyterian Hospital/Weill Medical Center, New York, NY, USA

    Michael W. Schuster

  9. Department of Medicine-Geriatrics, University of New York at Stony Brook VAMC, Northport, NY, USA

    Shing-Shing Yeh

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Laviano, A., Meguid, M.M., Fanelli, F.R. (2006). Anorexia. In: Mantovani, G., et al. Cachexia and Wasting: A Modern Approach. Springer, Milano. https://doi.org/10.1007/978-88-470-0552-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0552-5_13

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0471-9

  • Online ISBN: 978-88-470-0552-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation